Satoshi Miyamoto, Daiki Niizato, Dan Tomomasa, Akira Nishimura, Akihiro Hoshino, Takahiro Kamiya, Takeshi Isoda, Masatoshi Takagi, Michiko Kajiwara, Shohei Azumi, et al. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity. Journal of clinical immunology. 2024. 44. 6. 126-126
Yukari Sakurai, Fuminori Iwasaki, Ayana Hirose, Naoya Matsumoto, Naoyuki Miyagawa, Dai Keino, Tomoko Yokosuka, Satoshi Hamanoue, Masakatsu Yanagimachi, Masae Shiomi, et al. Metronomic Chemotherapy for Pediatric Refractory Solid Tumors: A Retrospective Single-Center Study. Journal of pediatric hematology/oncology. 2024
Hisashi Ishida, Yuki Arakawa, Daiichiro Hasegawa, Ikuya Usami, Yoshiko Hashii, Yasuyuki Arai, Satoshi Nishiwaki, Dai Keino, Keisuke Kato, Maho Sato, et al. Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia. Annals of hematology. 2023
Mayumi Hangai, Takahisa Kawaguchi, Masatoshi Takagi, Keitaro Matsuo, Soyoung Jeon, Charleston W K Chiang, Andrew T Dewan, Adam J De Smith, Toshihiko Imamura, Yasuhiro Okamoto, et al. Genome-wide assessment of genetic risk loci for childhood acute lymphoblastic leukemia in Japanese patients. Haematologica. 2023
Kohei Fukuoka, Jun Kurihara, Tomoko Shofuda, Naoki Kagawa, Kai Yamasaki, Ryo Ando, Joji Ishida, Masayuki Kanamori, Atsufumi Kawamura, Young-Soo Park, et al. Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study. Acta neuropathologica communications. 2023. 11. 1. 153-153
2021/06 - 神奈川県立こども医療センター こども医療センター優秀論文賞 Pilot study of the combination of sorafenib and fractionated irinotecan in pediatric relapse/refractory hepatic cancer (FINEX pilot study)
2017/05 - 東京小児がん研究グループ (TCCSG) 研究奨励賞 Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group